News summaryInvesting.comOct 21, 2026, 06:21 AM
FDA approves GSK’s Hibsago for chronic hepatitis B treatment
FDA approves GSK’s Hibsago for chronic hepatitis B treatment（摘要待生成）
Loading...
FDA approves GSK’s Hibsago for chronic hepatitis B treatment（摘要待生成）